Arnold, about 1 1/2 years ago we had a consultant come out to our site to speak on the importance of cGMP. This guy was a former CEO of a small biotech company in the Mass area.
He has heavy connections with Pfizer. In fact, all he seemed to mention was Pfizer. During one of our breaks I asked this guy if he had ever heard of Cytogenix. He told me he had heard of them, knew of their technology, and that it would be interesting to see if their story ever got a chance to unfold.
He told me in so many words that there are many pharmas watching what developes at Cytogenix. Since he had admitted to having close ties to Pfizer one can only assume that what he knows his sources at Pfizer know.
I was a bit surpirsed that this fellow knew about CYGX at first, but he let it be known that there is very little that gets past the pharma/biotech business because they are constantly looking for new pipelines and ways of doing things.
I have another friend who works at Merck whose sole job is to search for new technologies and read publications dealing with different aspects of pharma/biotech Mercj is also doing R&D on. She also knows of CYGX.
